Tectonic Therapeutic (TECX) Competitors $21.39 -0.36 (-1.66%) Closing price 04:00 PM EasternExtended Trading$21.41 +0.02 (+0.09%) As of 05:12 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock TECX vs. VERA, APGE, MESO, SPRY, GPCR, SDGR, OCUL, IDYA, DYN, and ARDXShould you be buying Tectonic Therapeutic stock or one of its competitors? The main competitors of Tectonic Therapeutic include Vera Therapeutics (VERA), Apogee Therapeutics (APGE), Mesoblast (MESO), ARS Pharmaceuticals (SPRY), Structure Therapeutics (GPCR), Schrödinger (SDGR), Ocular Therapeutix (OCUL), IDEAYA Biosciences (IDYA), Dyne Therapeutics (DYN), and Ardelyx (ARDX). These companies are all part of the "pharmaceutical products" industry. Tectonic Therapeutic vs. Vera Therapeutics Apogee Therapeutics Mesoblast ARS Pharmaceuticals Structure Therapeutics Schrödinger Ocular Therapeutix IDEAYA Biosciences Dyne Therapeutics Ardelyx Tectonic Therapeutic (NASDAQ:TECX) and Vera Therapeutics (NASDAQ:VERA) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, dividends, media sentiment, profitability, risk, earnings and community ranking. Which has more risk & volatility, TECX or VERA? Tectonic Therapeutic has a beta of 3.44, indicating that its share price is 244% more volatile than the S&P 500. Comparatively, Vera Therapeutics has a beta of 1.28, indicating that its share price is 28% more volatile than the S&P 500. Does the media refer more to TECX or VERA? In the previous week, Vera Therapeutics had 5 more articles in the media than Tectonic Therapeutic. MarketBeat recorded 14 mentions for Vera Therapeutics and 9 mentions for Tectonic Therapeutic. Vera Therapeutics' average media sentiment score of 1.35 beat Tectonic Therapeutic's score of 1.30 indicating that Vera Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tectonic Therapeutic 6 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Vera Therapeutics 10 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders and institutionals hold more shares of TECX or VERA? 62.6% of Tectonic Therapeutic shares are owned by institutional investors. Comparatively, 99.2% of Vera Therapeutics shares are owned by institutional investors. 9.2% of Tectonic Therapeutic shares are owned by insiders. Comparatively, 16.3% of Vera Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Do analysts recommend TECX or VERA? Tectonic Therapeutic currently has a consensus price target of $72.40, indicating a potential upside of 238.48%. Vera Therapeutics has a consensus price target of $65.70, indicating a potential upside of 157.34%. Given Tectonic Therapeutic's higher probable upside, equities analysts clearly believe Tectonic Therapeutic is more favorable than Vera Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tectonic Therapeutic 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 3.14Vera Therapeutics 0 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 3 Strong Buy rating(s) 3.18 Does the MarketBeat Community prefer TECX or VERA? Vera Therapeutics received 32 more outperform votes than Tectonic Therapeutic when rated by MarketBeat users. However, 100.00% of users gave Tectonic Therapeutic an outperform vote while only 66.67% of users gave Vera Therapeutics an outperform vote. CompanyUnderperformOutperformTectonic TherapeuticOutperform Votes10100.00% Underperform VotesNo VotesVera TherapeuticsOutperform Votes4266.67% Underperform Votes2133.33% Which has preferable valuation and earnings, TECX or VERA? Vera Therapeutics is trading at a lower price-to-earnings ratio than Tectonic Therapeutic, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTectonic TherapeuticN/AN/A$12.16M-$6.53-3.28Vera TherapeuticsN/AN/A-$95.99M-$2.75-9.28 Is TECX or VERA more profitable? Tectonic Therapeutic's return on equity of -35.53% beat Vera Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Tectonic TherapeuticN/A -35.53% -31.97% Vera Therapeutics N/A -50.13%-39.50% SummaryVera Therapeutics beats Tectonic Therapeutic on 9 of the 16 factors compared between the two stocks. Get Tectonic Therapeutic News Delivered to You Automatically Sign up to receive the latest news and ratings for TECX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TECX vs. The Competition Export to ExcelMetricTectonic TherapeuticBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$399.37M$2.95B$5.54B$7.98BDividend YieldN/A1.87%5.37%4.21%P/E Ratio-3.6330.3722.5618.87Price / SalesN/A479.72402.24106.74Price / CashN/A168.6838.1834.62Price / Book10.043.166.764.32Net Income$12.16M-$72.35M$3.22B$247.98M7 Day Performance6.00%0.93%3.04%2.81%1 Month Performance36.94%15.26%11.86%13.35%1 Year PerformanceN/A-24.22%16.40%4.35% Tectonic Therapeutic Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TECXTectonic Therapeutic2.8019 of 5 stars$21.39-1.7%$72.40+238.5%N/A$399.37MN/A-3.63120Upcoming EarningsNews CoveragePositive NewsVERAVera Therapeutics2.923 of 5 stars$23.41+0.8%$64.67+176.2%-41.7%$1.49BN/A-8.9740Upcoming EarningsAnalyst ForecastPositive NewsAPGEApogee Therapeutics2.1632 of 5 stars$37.79+2.6%$92.17+143.9%-26.0%$1.46BN/A-15.6291Upcoming EarningsNews CoveragePositive NewsMESOMesoblast1.6924 of 5 stars$11.41-3.5%$18.00+57.8%+60.7%$1.45B$5.67M0.0080Gap DownSPRYARS Pharmaceuticals3.0554 of 5 stars$14.14+2.7%$31.00+119.2%+48.3%$1.39B$89.15M-27.7390Upcoming EarningsNews CoveragePositive NewsGPCRStructure Therapeutics2.3408 of 5 stars$23.62-0.5%$81.29+244.1%-31.1%$1.35BN/A-31.92136Upcoming EarningsAnalyst ForecastPositive NewsSDGRSchrödinger2.4288 of 5 stars$25.75-2.6%$33.00+28.2%+6.8%$1.32B$207.54M-11.00790Upcoming EarningsPositive NewsOCULOcular Therapeutix3.5481 of 5 stars$8.13+5.4%$16.38+101.4%+42.6%$1.29B$63.72M-6.16230News CoverageGap DownIDYAIDEAYA Biosciences3.6715 of 5 stars$19.75+3.9%$53.58+171.3%-50.4%$1.29B$7M-5.9880Upcoming EarningsPositive NewsHigh Trading VolumeDYNDyne Therapeutics3.3388 of 5 stars$11.28+2.0%$47.46+320.8%-54.5%$1.28BN/A-3.17100Positive NewsARDXArdelyx4.4801 of 5 stars$5.35+1.7%$10.61+98.3%-52.6%$1.28B$333.62M-33.4490Earnings ReportAnalyst ForecastInsider TradeOptions VolumeAnalyst RevisionNews Coverage Related Companies and Tools Related Companies Vera Therapeutics Competitors Apogee Therapeutics Competitors Mesoblast Competitors ARS Pharmaceuticals Competitors Structure Therapeutics Competitors Schrödinger Competitors Ocular Therapeutix Competitors IDEAYA Biosciences Competitors Dyne Therapeutics Competitors Ardelyx Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TECX) was last updated on 5/5/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tectonic Therapeutic Please log in to your account or sign up in order to add this asset to your watchlist. Share Tectonic Therapeutic With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TECX Stock Free TECX Stock Alerts